Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K/Akt and SIRT1/PGC1α pathway

Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K/Akt and SIRT1/PGC1α pathway

Xiaoning Li,1 Shuhong Yang,1 Liang Wang,1 Peng Liu,1 Shuang Zhao,1 Huizhou Li,1 Yuqing Jiang,2 Yuexian Guo,2 Xiuli Wang1 1Department of Anesthesiology, The Third Hospital of Hebei Medical University, Qiaoxi District, Shijiazhuang 050051, China; 2Department of Urology, The Third Hospital of Hebei Med...

Full description

Bibliographic Details
Main Authors: Li X, Yang S, Wang L, Liu P, Zhao S, Li H, Jiang Y, Guo Y, Wang X
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Journal of Pain Research
Subjects:
Resveratrol
Paclitaxel
Neuropathicpain
PI3K/Akt
SIRT1/PGC1α;
Online Access:https://www.dovepress.com/resveratrol-inhibits-paclitaxel-induced-neuropathic-pain-by-the-activa-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/resveratrol-inhibits-paclitaxel-induced-neuropathic-pain-by-the-activa-peer-reviewed-article-JPR

Similar Items